Sveriges mest populära poddar

ERJ August 2017: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids

15 min•25 augusti 2017

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town, South Africa.

Fler avsnitt av ERS Publications Podcasts

ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD

28 aug.•10 min

ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis

12 aug.•11 min

ERS Monograph: Thoracic Ultrasound

10 aug.•16 min

ERJ Podcast June 2026: The ageing lung

16 juli•14 min

ERJ Podcast May 2026: Mucus plugs in asthma and COPD

21 maj•17 min

ERS Monograph: Bronchiectasis

7 maj•19 min

ERJ Podcast April 2026: Use of spirometry to define airflow obstruction and diagnose COPD

1 maj•14 min

ERJ Podcast March 2026: Mortality in severe asthma

30 mars•12 min

ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma

19 feb.•16 min

ERS Monograph: Chronic Cough

13 feb.•27 min

ERS Publications Podcasts med ERS Publications Podcasts finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.